Alnylam Pharmaceuticals
ALNY
#637
Rank
C$44.95 B
Marketcap
$347.23
Share price
-0.07%
Change (1 day)
73.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company